IDEXX Laboratories Aktie
WKN: 888210 / ISIN: US45168D1046
01.05.2025 12:59:53
|
IDEXX Laboratories Inc Q1 Profit Advances, Beats Estimates
(RTTNews) - IDEXX Laboratories Inc (IDXX) released earnings for its first quarter that increased from last year and beat the Street estimates.
The company's bottom line came in at $242.7 million, or $2.96 per share. This compares with $235.6 million, or $2.81 per share, last year.
Analysts on average had expected the company to earn $2.84 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 3.6% to $998.4 million from $964.1 million last year.
IDEXX Laboratories Inc earnings at a glance (GAAP) :
-Earnings: $242.7 Mln. vs. $235.6 Mln. last year. -EPS: $2.96 vs. $2.81 last year. -Revenue: $998.4 Mln vs. $964.1 Mln last year.
-Guidance: Full year EPS guidance: $11.93 - $12.43 Full year revenue guidance: $4.095-$4.210 Bln

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEXX Laboratoriesmehr Nachrichten
Analysen zu IDEXX Laboratoriesmehr Analysen
Aktien in diesem Artikel
IDEXX Laboratories | 456,50 | 0,77% |
|